MXCT · Maxcyte, Inc.
Market Cap
$127.98M
Shares
103.21M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Maher Masoud | President and Chief Executive Officer | $2,687,657 |
| Douglas Swirsky | Former Chief Financial Officer | $1,225,057 |
| Ali Soleymannezhad | Former Chief Commercial Officer | $1,135,169 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Maher Masoud | President and Chief Executive Officer | $3,611,298 |
| Douglas Swirsky | Chief Financial Officer Ali Soleymannezhad Chief Commercial Officer | $1,686,574 |
| Ali Soleymannezhad | Former Chief Commercial Officer | $1,021,833 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Doug Doerfler | Former President and Chief Executive Officer | $3,136,284 |
| Douglas Swirsky | Chief Financial Officer Ali Soleymannezhad Chief Commercial Officer | $1,189,934 |
| Maher Masoud | President and Chief Executive Officer | $890,365 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Doug Doerfler | Former President and Chief Executive Officer | $1,575,317 |
| Maher Masoud | President and Chief Executive Officer, former Executive Vice President | $790,871 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Doug Doerfler | President, Chief Executive Officer and Director Cenk Sumen Chief Scientific Officer | $2,036,924 |
| Ron Holtz | Chief Financial Officer | $948,332 |
| Amanda Murphy | Former Chief Financial Officer | $830,622 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Amanda Murphy | Former Chief Financial Officer | $2,778,295 |
| Doug Doerfler | President, Chief Executive Officer and Director | $1,223,727 |